Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese.

Trial Profile

Effects of Low-Dose Leptin on the Metabolic/Behavioral Phenotypes of the Formerly-Obese.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Leptin (Primary)
  • Indications Obesity
  • Focus Pharmacodynamics
  • Most Recent Events

    • 30 Apr 2013 Planned End Date 1 Jul 2015 added as reported by ClinicalTrials.gov.
    • 30 Apr 2013 Status changed from completed to recruiting as reported by ClinicalTrials.gov.
    • 23 Jan 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top